Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-214,621
Closed -$1.5M 3460
2025
Q1
$1.5M Sell
214,621
-4,017
-2% -$26.9K ﹤0.01% 2458
2024
Q4
$748K Hold
218,638
﹤0.01% 2826
2024
Q3
$842K Sell
218,638
-305,414
-58% -$1.2M ﹤0.01% 2834
2024
Q2
$1.88M Sell
524,052
-535,147
-51% -$4.05M ﹤0.01% 2423
2024
Q1
$11.1M Buy
1,059,199
+182,840
+21% +$2.08M ﹤0.01% 1528
2023
Q4
$10.5M Sell
876,359
-1,070
-0.1% -$9.16K ﹤0.01% 1558
2023
Q3
$9.28M Sell
877,429
-287,630
-25% -$3.77M ﹤0.01% 1521
2023
Q2
$15.7M Buy
1,165,059
+340,737
+41% +$4.42M 0.01% 1234
2023
Q1
$11.9M Buy
824,322
+270,757
+49% +$3.06M ﹤0.01% 1376
2022
Q4
$4.31M Buy
553,565
+240,314
+77% +$2.29M ﹤0.01% 1997
2022
Q3
$3.58M Buy
313,251
+3,813
+1% +$41.6K ﹤0.01% 2090
2022
Q2
$2.29M Sell
309,438
-154,419
-33% -$1.35M ﹤0.01% 2366
2022
Q1
$7.27M Buy
463,857
+261,454
+129% +$4.81M ﹤0.01% 1841
2021
Q4
$5.34M Sell
202,403
-9,648
-5% -$316K ﹤0.01% 2080
2021
Q3
$8.94M Sell
212,051
-39,643
-16% -$1.86M ﹤0.01% 1860
2021
Q2
$13.7M Buy
251,694
+139,782
+125% +$6.79M ﹤0.01% 1658
2021
Q1
$5.08M Buy
111,912
+61,999
+124% +$2.98M ﹤0.01% 2164
2020
Q4
$2.17M Buy
49,913
+6,488
+15% +$288K ﹤0.01% 2468
2020
Q3
$1.69M Buy
+43,425
New +$1.5M ﹤0.01% 2464

Other funds holding ACCD

Nuveen's ACCD Position: Q2 2025 in Review

Nuveen sold out of Accolade Inc (ACCD) in Q2 2025, closing a stake of 214,621 shares — an estimated $1.5M sold.

Nuveen first reported a position in ACCD in Q3 2020 and held it in 19 quarters. The position peaked at $15.7M in Q2 2023. 1 fund tracked by Wall St. Rank holds ACCD as of Q2 2025.

  • Nuveen reported no remaining Accolade Inc position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 214,621 Accolade Inc shares in Q2 2025, an estimated $1.5M.
  • Nuveen first reported a position in Accolade Inc in Q3 2020 and held it in 19 quarters.
  • Nuveen's Accolade Inc position peaked at $15.7M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Accolade Inc as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.